We are pleased to announce our 2017 World Preclinical Congress Distinguished Faculty:
Adam Best, Ph.D., Product Manager, DiscoverX Corporation
Adi Diab, M.D., Assistant Professor, Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
Adrian J. Fretland, Ph.D., Associate Director, DMPK Oncology iScience, AstraZeneca
Adrienne Watson, Ph.D., Senior Research Scientist, Surrogen, A Recombinetics Company
Alejandro Villagra, Ph.D., Assistant Professor, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University
Alison Harrill, Ph.D., Geneticist, National Toxicology Program Division, National Institute for Environmental Health Sciences
Amitabh Sharma, Ph.D., Assistant Professor, Department of Medicine, Brigham & Women’s Hospital and Harvard Medical School
Andrea T. Hooper, Ph.D., Senior Principal Scientist, Pfizer Oncology
Andrew Flick, Ph.D., Senior Principal Scientist, Global R&D, Pfizer, Inc.
Andrew J. Phillips, Ph.D., President and CSO, C4 Therapeutics
Andrew Ravanelli, Ph.D., Senior Research & Development Scientist, Genome & Epigenome Editing, MilliporeSigma
Andrew Wang, M.D., Associate Professor, Director of Clinical and Translational Research, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill
Andy Zhu, Ph.D., Senior Manager, Department of Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International
Angie Inkyung Park, Ph.D., Senior Director, Immunotherapy and Stem Cells, OncoMed Pharmaceuticals
Anil K. Sood, M.D., Professor, Department of Gynecologic Oncology and Department of Cancer Biology, MD Anderson Cancer Center
Anil Vasudevan, Ph.D., Director, Discovery Chemistry and Technology (DCAT), AbbVie
Anka G. Ehrhardt, Ph.D., Director, Clinical Cytometry, Translational Medicine, BMS
Annette Gilchrist, Ph.D., Professor, Pharmacology, Midwestern University
Annick D. Van Den Abbeele, M.D., Associate Professor, Radiology, Harvard Medical School; Chief, Department of Imaging, Dana-Farber Cancer Institute; Founding Director, Center for Biomedical Imaging in Oncology (CBIO), Imaging, Dana-Farber Cancer Institute
Antti Nurmi, Ph.D., Managing Director, Discovery, Charles River
Apostolos Pappas, Ph.D., Research Manager and Fellow, Emerging Science and Innovation, Johnson & Johnson Consumer, Inc.
Ariamala Gopalsamy, Ph.D., Associate Research Fellow, Medicine Design, Pfizer, Inc.
Atwood Cheung, Ph.D., Investigator III, Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Inc.
Axel H. Meyer, Ph.D., Head of Brain Delivery, Neuroscience Discovery, AbbVie GmbH & Co. KG
Ayman El-Kattan, Ph.D., Associate Research Fellow, Pdm, Pfizer
Azusa Tanaka, Ph.D., Product Manager, Precision Research Model, Taconic Biosciences
Balu Chakravarthy, Ph.D., Senior Research Officer, National Research Council Canada
Benjamin G. Cuiffo, Ph.D., Scientist, Biomodels, LLC
Bernard Faller, Director, Discovery ADME, Novartis Institutes for BioMedical Research, Basel
Bernard Faller, Ph.D., Director Discovery ADME, Novartis Institutes for BioMedical Research, Basel, Switzerland
Birgitt Schuele, M.D., Director for Gene Discovery and Stem Cell Modeling, Translational Sciences, Parkinson’s Institute and Clinical Center
Brandon Lamarche, Ph.D., Research Scientist, ACEA Biosciences
Brian B. Haines, Ph.D., Principal Scientist, Pharmacology, Merck
Brian Czerniecki, M.D., Ph.D., Chair and Senior Member, Department of Breast Oncology, Moffitt Cancer Center
Brian Lamon, Ph.D., Head, II-ON & Lead, Oncology Academic Research, BMS
Carol Moraff, Scientific Associate I, Novartis Institutes for BioMedical Research
Celia Dominguez, Ph.D., Vice President, Chemistry, CHDI Management/CHDI Foundation Inc.
Cem Girit, Ph.D., CEO, Biopticon Corporation
Ceren Korkut, Ph.D., Scientist, Chemical Biology, Biogen
Changning Wang, Ph. D., Instructor, Martinos Center, Massachusetts General Hospital
Chengzu Long, Ph.D., Assistant Professor, Division of Cardiology, New York University School of Medicine
Chi-Ping Day, Ph.D., Staff Scientist, Cancer Modeling Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health
Christian Schmees, Ph.D., Head of Tumor Biology, Molecular Biology Department, NMI Natural and Medical Sciences Institute at the University of Tübingen
Christiane Chbib, Pharm.D, Ph.D., Assistant Professor, Pharmaceutical Sciences, Larkin College of Pharmacy
Christoph Patsch, Ph.D., Principle Scientist, Team Lead, Stem Cell Assays, Roche Innovation Center
Christopher Bunker, Ph.D., Vice President, Business Development, Advanced Cell Diagnostics, Inc.
Christopher Heery, M.D., CMO, Bavarian Nordic
Christopher Lock, B.Sc., Ph.D., Senior Scientist, Discovery, Charles River
Christopher Schulze, Ph.D., Postdoctoral Research Fellow, Pathology (Bogyo Lab), Stanford University School of Medicine
Chudi Ndubaku, Ph.D., Associate Director, Organic Synthetic Chemistry, Aduro Biotech
Chunxiao Xu, Ph.D., Principal Scientist, Immuno-Pharmacology and Immuno-Oncology, EMD Serono
Claudia McGinnis, Ph.D., Principal Scientist & Group Leader, Pharma Research and Early Development, Pharmaceutical Sciences, Mechanistic Safety, Roche Innovation Center Basel
Clifford Steer, M.D., Professor of Medicine and Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School
Craig Ferris, Ph.D., Professor, Psychology and Pharmaceutical Sciences, Director, Center for Translational NeuroImaging, Northeastern University
Cristianne J.F. Rijcken, Pharm.D., Ph.D., Founder and CSO, Cristal Therapeutics
Cynthia Guidos, Ph.D., Senior Scientist, Program in Developmental & Stem Cell Biology, Hospital for Sick Children Research Institute, Peter Gilgan Centre for Research and Learning
Dag Sehlin, Ph.D., Researcher, Department of Public Health/Geriatrics, Uppsala University, Ph.D., Assistant Professor, Radiology, Johns Hopkins University
Danica Stanimirovic, M.D., Ph.D., Director, Translational Bioscience Department, Human Health Therapeutics Portfolio, National Research Council of Canada
Daniel G. Anderson, Ph.D., Associate Professor, Department of Chemical Engineering, Institute for Medical Engineering and Science, Harvard-MIT Division of Health Sciences & Technology, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Daniel Haag, Ph.D., CSO, NeuCyte
Daniel Kagan, Ph.D., COO, Scientist
Daniela Cipolletta, Ph.D., Lab Head, Investigator III, Immuno-Oncology, Novartis Institutes for BioMedical Research
Danielle Graham, Ph.D., Director, Neurodegenerative Disease, Biomarker Discovery and Development, Biogen
Danilo A. Tagle, Ph.D., MS, Associate Director, Special Initiatives, Office of the Director, National Center for Advancing Translational Sciences (NCATS), NIH
Danilo Maddalo, Ph.D., Lab Head, ONC Pharmacology, Novartis Institutes for BioMedical Research, Novartis Pharma AG
Dario Vignali, Ph.D., Vice Chair and Professor of Immunology, University of Pittsburgh School of Medicine
David Bumcrot, Ph.D., Senior Director, Molecular & Cell Biology, Editas Medicine
David Tuck, M.D., CMO, Curis, Inc.
Dean C. Bottino, Ph.D., Scientific Director, Quantitative Clinical Pharmacology, Takeda Pharmaceuticals International
Denise Faustman, M.D., Ph.D., Director, Immunobiology & Associate Professor, Medicine, Immunobiology, Massachusetts General Hospital, Harvard Medical School
Denise Karaoglu Hanzatian, Ph.D., Principal Research Scientist, Biologics Discovery, AbbVie Bioresearch Center, AbbVie
Diane Hoffman-Kim, Ph.D., Associate Professor, Medical Science and Engineering, Brown University
Donald E. Ingber, M.D., Ph.D., Founding Director, Wyss Institute for Biologically Inspired Engineering, Harvard University; Judah Folkman Professor of Vascular Biology, Harvard Medical School & Boston Children’s Hospital; and Professor of Bioengineering, John A. Paulson School of Engineering & Applied Sciences, Harvard University
Dong Chen, Ph.D., Professor, Institute of Process Equipment, College of Energy Engineering, Zhejiang University
Douglas Wilson, Ph.D., Associate Principal Scientist, Merck
Elaine Hurt, Ph.D., Senior Scientist, MedImmune
Elizabeth Evans, Ph.D., Vice President, Preclinical Research, Vaccinex
Emer Leahy, Ph.D., President & CEO, PsychoGenics Inc.
Eric Kmiec, Ph.D., Director, Gene Editing Program and Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System
Eric Yvon, Ph.D., Director, CAR Program, Research and Development, Bellicum Pharmaceuticals, Inc.
Fabrizio Piazza, Ph.D., Principal Investigator, iCAβ International Network Coordinator, School of Medicine, University of Milano-Bicocca
Frank S. Walsh, Ph.D., CEO, Ossianix
G. Ian Gallicano, Ph.D., Associate Professor, Department of Biochemistry and Molecular & Cellular Biology, and Director, Transgenic Core Facility, Georgetown University Medical Center
Gary C. Starling, Ph.D., Associate Vice President, MRL Biologics and Vaccines Discovery, Merck
Gary Gintant, Ph.D., Senior Research Fellow, Integrative Pharmacology, Integrated Science and Technology, AbbVie
Geoffrey Bartholomeusz, Ph.D., Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center
George M. Burslem, Ph.D., Research Associate, Molecular, Cellular and Developmental Biology, Yale University
Gerd Wagner, Ph.D., Reader in Medicinal Chemistry, Department of Chemistry, King’s College London
Graham Smith, Ph.D., Director, Director Medicinal Chemistry, New Modalities, Medicinal Chemistry, Merck Research Laboratories
Gursatya "Guru" Singh, PSM, Director, Scientific Content, Scientist.com
Hao Yin, Ph.D., Research Scientist, The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Harvey Cantor, M.D., Baruj Benacerraf Professor, Microbiology & Immunobiology; Chairman, Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute
Henning Mann, Ph.D., Scientific Director, Nortis, Inc.
Henning Stockmann, Ph.D., Senior Scientist, Chemical Biology, Global Pharmaceutical Research and Development, AbbVie Inc.
Hiruy Meharena, Ph.D., Postdoctoral Fellow, Tsai Lab, Massachusetts Institute of Technology (MIT)
Hua Xu, Ph.D., Principal Scientist, Medicine Design, Pfizer
Ian Foe, Ph.D., Research Scientist, Bogyo Lab, Department of Pathology, Stanford University School of Medicine
Ian McNiece, Ph.D., Executive Consultant, CellMed Consulting
Ian Sweet, Ph.D., Associate Professor, Department of Medicine, University of Washington
James E. Talmadge, Ph.D., Professor Department of Pathology and Microbiology, Director Laboratory of Transplantation Immunology, Editor-in-Chief International Immunopharmacology, Transplantation Immunopharmacology, University of Nebraska Medical Center
James J. Hickman, Ph.D., Professor, Nanoscience Technology, Chemistry, Biomolecular Science, and Electrical Engineering, University of Central Florida
James Kasuboski, Ph.D., Postdoctoral Fellow, Neuroscience, Pfizer
James Smothers, Ph.D., Senior Director & Head, Discovery, Immuno-Oncology & Combinations DPU, GlaxoSmithKline
Jarrod Marto, Ph.D., Associate Professor, Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute
Javier Terriente, Ph.D., CSO, Research & Development, ZeClinics
Jayaprakasam Bolleddula, Ph.D., Senior Scientist II (Associate Director), Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals
Jean-Francois Mirjolet, Ph.D., Technology Director, Oncodesign
Jeff Irelan, Ph.D., Director, Scientific Applications, Tissue Operations, Organovo
Jeffrey Borenstein, Ph.D., Laboratory Technical Staff, Biomedical Microsystems, Draper
Jeffrey Hanke, Ph.D., CSO, Tesaro
Jeffrey Johannes, Ph.D., Associate Principal Scientist, IMED Oncology Medicinal Chemistry, AstraZeneca
Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines
Jennifer Listgarten, Ph.D., Senior Researcher, Microsoft Research
Jennifer Smith, Ph.D., Assistant Director, ICCB-Longwood Screening Facility, Harvard Medical School
Jijie Gu, Ph.D., Research Fellow, Immunology and Global Biologics, AbbVie Bioresearch Center
Jing (Jeannie) Li, Ph.D., Senior Scientist, Medicinal Chemistry Chemical Biology, Pfizer
Johan Luthman, Ph.D., Vice President, Neuroscience Clinical Development, Neurology Business Group, Eisai, Inc
Johan Ulrik Lind, Ph.D., Research Associate, Disease Biophysics Group, John A. Paulson School of Engineering and Applied Sciences, Wyss Institute for Biologically Inspired Engineering, Harvard University
John Doench, Ph.D., Associate Director, Genetic Perturbation Platform, Broad Institute of Harvard and MIT
John Erve, Ph.D., Consultant
John G. Quinn, Ph.D., Head of Molecular Biophysics & Senior Scientist, Biochemistry & Cellular Pharmacology, Genentech a member of the Roche Group
John P. Wikswo, Ph.D., Founding Director, Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, Vanderbilt University
John Santa Maria, Ph.D., Research Fellow, Cheminformatics, Merck
Jonathan Levenson, Ph.D., Senior Director, Preclinical Research and Development, Proclara Biosciences
Jonathan Zalevsky, Ph.D., Vice President, Biology & Preclinical Development, Nektar Therapeutics
Jose A. Lebron, Ph.D., Executive Director, Investigative Laboratory Sciences, Safety Assessment & Laboratory Animal Resources, Merck & Co., Inc.
Joseph Charest, Ph.D., Program Manager, Biomedical Solutions, Draper
Jürgen Moll, Ph.D., Director, Pharmacology and Translational Research, Boehringer Ingelheim
Kap-Sun Yeung, Ph.D., Principal Scientist, Discovery Chemistry, Bristol-Myers Squibb
Karuppiah Kannan, Ph.D., Associate Director, Cancer Pharmacology, Takeda Pharmaceuticals International
Katherine Bakshian Chiappinelli, Ph.D., Assistant Professor, Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University Cancer Center
Kent Werner, M.D., Ph.D., Co-Founder and CEO, Cogentis Therapeutics; Johns Hopkins Neurology Adjunct Faculty
Kevin C. Eggan, Ph.D., Harvard Department of Stem Cell and Regenerative Biology, Director of Stem Cell Biology, Stanley Center for Psychiatric Research at the Broad Institute
Kevin C. Eggan, Ph.D., Harvard Department of Stem Cell and Regenerative Biology, Howard Hughes Medical Institute
Kevin Holden, Ph.D., Head, Synthetic Biology, Synthego
Kevin Lumb, Ph.D., Global Head of Screening, Discovery Sciences, The Janssen Pharmaceutical Companies of Johnson & Johnson
Kieran F. Geoghegan, Ph.D., Research Fellow, Pfizer Worldwide Research
Kimberly Homan, Ph.D., Research Associate, Lewis Research Group, Wyss Institute for Biologically Inspired Engineering, Harvard University
Klara Valko, Ph.D., Director/Honorary professor, Bio-Mimetic Chromatography
Kohei Shigeta, M.D., Ph.D., Research Fellow, Duda Lab, Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School
Kurt A. Schalper, M.D., Ph.D., Assistant Professor of Pathology and Medicine (Medical Oncology), Yale School of Medicine, Director, Translational Immuno-Oncology Laboratory, Yale Cancer Center
Larry Park, Ph.D., Director, In Vivo Research, CHDI
Laszlo Urban, M.D., Ph.D., Global Head, Preclinical Secondary Pharmacology, Novartis Institutes for BioMedical Research, Inc.
Lawrence Tamarkin, Ph.D., President & CEO, CytImmune
Lee Rubin, Ph.D., Professor, Stem Cell & Regenerative Medicine, Harvard University; Director, Translational Medicine, HSCI
Leigh Zawel, Vice President and Site Head, New York and Boston Centers for Therapeutic Innovation, Pfizer
Leonard Khiroug, Ph.D., CSO, Neurotar Ltd
Lieven Meerpoel, Ph.D., Senior Director, Janssen Lead Discovery, Janssen R&D
Lijun Sun, Ph.D., Director, Center for Drug Discovery and Translational Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Lois A. Lampson, Ph.D., Associate Professor of Neurosurgery, Brigham & Women’s Hospital/Harvard Medical School
Lorenzo Galluzzi, Ph.D., Assistant Professor of Cell Biology Research, Radiation Oncology, Weill Cornell, Weill Cornell Medical College
Luise U. Weigand, Ph.D., Team Leader, Cell Biology, Immunocore Ltd.
Lyn Jones, Ph.D., Head of Rare Diseases Chemistry, Chemical Biology Group Leader, Pfizer Inc.
Madhu Lal-Nag, Ph.D., Group Leader, Trans-NIH RNAi Facility, National Center for Advancing Translational Sciences, National Institutes of Health
Malte Tiburcy, M.D., Research Fellow, Institute of Pharmacology and Toxicology, University Medical Center Goettingen
Manfred Kraus, Ph.D., Director, In vivo Pharmacology, Tumor Cell Biology, Pfizer Oncology
Manu Sebastian, Ph.D., Associate Professor and Director, Research Histology, Pathology & Imaging Core, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center
Manuel Sanchez-Felix, Senior Fellow, Chemical & Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, Cambridge
Manuela Polydoro, Ph.D., Investigator II, Neuroscience, Novartis Institutes for BioMedical Research, Inc.
Marcus Bosenberg, M.D., Ph.D., Associate Professor of Dermatology and Pathology, Yale University, Co-Leader, Genomics, Genetics and Epigenetics Program, Yale Cancer Center
Mario Perro, Ph.D., Group Leader, Pharmacology, Oncology, Roche
Mark Smythe, Ph.D., Founder & VP, Protagonist Therapeutics
Martin Pettersson, Ph.D., Associate Research Fellow, Neuroscience & Pain Medicinal Chemistry, Pfizer Inc.
Mary Ellen Cvijic, Ph.D., Director, Lead Evaluation & Lead Profiling, Department of Lead Discovery and Optimization, Bristol-Myers Squibb
Mary Woodall-Jappe, Ph.D., Director, US Discovery Biology-Oncology, Eisai
Matt Gevaert, Ph.D., CEO and Co-Founder, KIYATEC
Matt Lucas, Ph.D., Director, Medicinal Chemistry, Yumanity Therapeutics
Matthew Robers, Senior Research Scientist, Research & Development, Promega Corporation
Mazhar Adli, Ph.D., Assistant Professor, Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine
Melissa Kelley, Ph.D., Senior Research & Development Leader, Dharmacon, part of GE Healthcare
Michael A. Curran, Ph.D., Assistant Professor, Immunology, The University of Texas MD Anderson Cancer Center
Michael Bassik, Ph.D., Assistant Professor, Department of Genetics, Stanford University
Michael Brehm, Ph.D., Associate Professor, The Robert and Sandra Glass Term Chair in Diabetes, Diabetes Center of Excellence, Program in Molecular Medicine, University of Massachusetts Medical School
Michael Burnet, Ph.D., Managing Director, Oncology Discovery, Synovo GmbH
Michael K. Ahlijanian, Ph.D., Director, Discovery Biology and Head, Clinical Biomarkers, Bristol-Myers Squibb
Michael Michaelides, Ph.D., Head, Oncology Chemistry, Senior Research Fellow, AbbVie
Michael P. Clark, Director, Department of Chemistry, Vertex Pharmaceuticals Inc.
Michael Hiatt, Scientist, Research & Development, STEMCELL Technologies, Inc.
Michael Rosenzweig, D.V.M., Ph.D., Executive Director, Oncology-Discovery, Merck Research Laboratories
Michel Bouvier, Ph.D., Professor/General Director, Biochemistry and Molecular Medicine/Institute for Research in Immunology and Cancer, Université de Montréal
Mingxiang Liao, Ph.D., Senior Scientist I, DMPK, Takeda Pharmaceutical Intl. Company
Mohammad F. Kiani, Ph.D., FAHA, Professor, Mechanical Engineering, Bioengineering, and Radiation Oncology, Temple University
Murali Gopalakrishnan, Ph.D., Senior Director, Head Search & Evaluation Neuroscience, AbbVie
Nadine Tatton, Ph.D., Scientific Director, The Association for Frontotemporal Degeneration
Natalie Artzi, Ph.D., Assistant Professor, Medicine, Brigham and Women’s Hospital
Nazish Sayed, M.D., Ph.D., Instructor, Cardiovascular Institute, Stanford University School of Medicine
Nello Mainolfi, Ph.D., Senior Director, Head of Drug Discovery, Raze Therapeutics
Neville Sanjana, Ph.D., Core Faculty Member, New York Genome Center and Assistant Professor, Department of Biology & Center for Genomics and Systems
Nicolo Fusi, Ph.D., Researcher, Microsoft Research
Norbert Perrimon, Ph.D., Professor, Department of Genetics, Harvard Medical School
Noushin Dianat, Ph.D., Bioengineering Team Leader, Colloids & Divided Materials Lab, ESPCI Paris
Olaf Hardt, Manager, Research & Development, Oncology, Miltenyi Biotec GmbH
Osama Rahma, M.D., Assistant Professor, Medicine, Center for Immuno-Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School
Pablo Perez-Pinera, M.D., Ph.D., Assistant Professor, Department of Bioengineering, University of Illinois at Urbana-Champaign
Patricia Ganey, Ph.D., Professor, Department of Pharmacology and Toxicology, Institute for Integrative Toxicology, Michigan State University
Patrick Sweeney, Ph.D., Managing Director, DRS Finland, Charles River Laboratorie
Paul B. Watkins, M.D., Director, Institute for Drug Safety Sciences, Howard Q. Ferguson Distinguished Professor, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
Paul Diehl, Ph.D., COO, Cellecta, Inc.
Paul Enríquez, J.D., LL.M., Ph.D. Candidate, Structural and Molecular Biochemistry, North Carolina State University
Paul Trippier, Ph.D., Assistant Professor, Pharmaceutical Sciences, Texas Tech University Health Sciences Center
Paula Miliani de Marval, Ph.D., Research Associate Director, Charles River
Per-Ola Freskgard, Ph.D., Vice Director and Senior Leader, Neuroscience, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.
Peter Cook, Ph.D., Postdoctoral Researcher, Laboratory of Andrea Ventura, M.D., Ph.D., Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center
Peter Hammerman M.D., Ph.D., Global Head, Translational Research, Oncology, Novartis
Peter Kutchukian, Ph.D., Associate Principal Scientist, Cheminformatics, Merck
Piyush Bajaj, Ph.D., Senior Scientist, Drug Safety R&D, Investigative Toxicology Group, Pfizer
Pottayil G. Sasikumar, Ph.D., Associate Research Director, Medicinal Chemistry, Aurigene Discovery Technologies Ltd.
Prabhakar Pandian, Ph.D., Chief Technology Officer, SynVivo, Inc.
Pradip Majumder, Ph.D., CSO, Mitra Biotech
Puja Sapra, Executive Director, Oncology Research and Development, Pfizer
Qin Wang, Ph.D., Principal Scientist, Translational Sciences, Biogen
Quang-Dé Nguyen, Ph.D., Director, Lurie Family Imaging Center, Senior Scientist, Center for Biomedical Imaging in Oncology, Research Associate in Radiology, Harvard Medical School
R. James Christie, Scientist, Antibody Discovery and Protein Engineering, MedImmune Research
Rachel Tsui, Staff Scientist, Science Exchange
Ricardo Dolmetsch, Ph.D., Global Head, Neuroscience, Novartis Institutes for Biomedical Research
Robert D. Bell, Ph.D., Senior Principal Scientist, Neurovascular Biology Lab Head, Pfizer, Inc.
Robert Hofmeister, Ph.D., CSO, TCR2 Therapeutics, Inc.
Robert Pearlstein, Ph.D., Senior Research Investigator I, Novartis Institutes for BioMedical Research
Robin Kleiman, Ph.D., Director, Preclinical Research, Translational Neuroscience Center, Boston Children’s Hospital
Robyn S. Klein, M.D., Ph.D., Director, Center for Neuroimmunology & Neuroinfectious Diseases, Department of Internal Medicine, Neurobiology, Pathology & Immunology, Washington University School of Medicine
Roderick Beijersbergen, Ph.D., Group Leader, Netherlands Cancer Institute and Head, NKI Robotics and Screening Center
Ronald Alfa, Ph.D., Director, Translational Biology, Recursion Pharmaceuticals
Ru Gunawardane, Ph.D., Director, Stem Cells and Gene Editing, Allen Institute for Cell Science
Ruben Boado, Ph.D., Vice President, Research & Development/Co-Founder, ArmaGen, Inc.
Salvador Ventura, Ph.D., Professor/Group Leader, Department of Biochemistry and Molecular Biology, Institute of Biotechnology and Biomedicine, Autonomous University of Barcelona
Sangeetha Palakurthi, Ph.D., Head of Cancer Biology and Pharmacology, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute
Sanjay Prakadan, Ph.D., The Shalek Lab, MIT Institute for Medical Engineering & Science
Sarah Javaid, Ph.D., Senior Scientist, Discovery Pharmacogenomics, Genetics, Pharmacogenomics, Merck
Scott Collins, Ph.D., Scientist, Novartis Institutes for BioMedical Research Inc
Scott Lokey, Ph.D., Professor, PBSci-Chemistry & Biochemistry Department, Physical & Biological Sciences, University of California Santa Cruz
Sean P. Brown, Ph.D., Principal Scientist, Medicinal Chemistry, Amgen
Sean Mackay, CEO, IsoPlexis
Serena Silver, Ph.D., Senior Investigator, Group Leader, Molecular Pharmacology, Novartis Institutes for BioMedical Research
Seyoum Ayehunie, Ph.D., Vice President, MatTek Corporation
Shane Olwill, Ph.D., Vice President, Head of Development & Immuno-Oncology, Pieris Pharmaceuticals
Sharin Roth, Ph.D., Director, Clinical Pharmacology, Bioanalytical & Biomarkers, Otsuka Pharmaceuticals
Shawn Je, Ph.D., Assistant Professor, Program in Neuroscience and Behavioral Disorders, Duke-National University of Singapore Medical School
Shawna Jackman, Ph.D., DABT, Principal Research Scientist, Photobiology, Charles River Laboratories
Shruthi Agrawal, Ph.D., Director, Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb Co.
Sid Topiol, Ph.D., CSO, 3D-2drug, LLC; Professor and Director, Structural and Computational Drug Discovery, Stevens Institute of Technology
Simrit Parmar, M.D., Assistant Professor, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Soner Altiok, MD, Ph.D., CSO, Nilogen Oncosystems
Stefano Crosignani, Ph.D., Director, Medicinal Chemistry, iTeos Therapeutics
Stephen J. Shuttleworth, Ph.D., FRSC CChem, CSO, Karus Therapeutics Ltd.
Stephen Young, Ph.D., Vice President, Business Development, Sygnature Discovery Ltd.
Suresh Kumar, Ph.D., Director, R&D, Progenra, Inc.
Suzanne Skolnik, Investigator, Analytical Chemistry Group, Novartis Institutes for BioMedical Research, Cambridge
Svetlana Hamm, Ph.D., Head, Translational Pharmacology, 4SC Group
Svetlana Sadekova, Ph.D., Senior Principal Scientist, Head of Translational Pathology Group, Merck
Terry Kenakin, Ph.D., Professor, Department of Pharmacology, University of North Carolina School of Medicine
Terry Van Vleet, Ph.D., DABT, Head of Molecular and Computational Toxicology, Department of Preclinical Safety, Abbvie
Theresa D’Souza, Ph.D., Section Manager, Cell Biology Research & Technology, Lonza Walkersville, Inc.
Thomas Oliver Kleen, Ph.D., Executive Vice President, Immune Monitoring, Epiontis GmbH
Tim Robertson, Ph.D., CEO, Vium
Torben Moos, Ph.D., The Faculty of Medicine, Department of Health Science and Technology, Laboratory of Neurobiology, Aalborg University
Tracy L. Young-Pearse, Ph.D., Assistant Professor, Neurology, Brigham and Women’s Hospital and Harvard Medical School
Travis Beckett, M.S., Scientist, Flow Cytometry Team Lead, Technology Research & Development, Juno Therapeutics
Tricia A. Thornton-Wells, Ph.D., Investigator III / Clinical Genetics Expert, Neuroscience Disease Area Portfolio Leader, Novartis Institutes for BioMedical
Tricia May-Dracka, Ph.D., Scientist II, Chemistry and Molecular Therapeutics, Biogen
Ulrich Broeckel, M.D., Professor of Pediatrics, Medicine and Physiology, Pediatrics, Medical College of Wisconsin
Vasileios Askoxylakis, M.D., Ph.D., Medical Director, Merrimack Pharmaceuticals
Walter C. Low, Ph.D., Professor and Associate Head for Research, Department of Neurosurgery, Stem Cell Institute, University of Minnesota Medical School
Weiming Xia, Ph.D., Acting Associate Director of Research, Geriatric Research Education Clinical Center, Bedford VA Hospital
Will Proctor, Ph.D., Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech
William Proctor, Ph.D., DABT, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech, Inc
William Z. Potter, M.D., Ph.D., Senior Advisor, National Institute of Mental Health
Winston Ko, CEO, Genervon Biopharmaceuticals, LLC
Xingxing Zang, Ph.D., Associate Professor, Microbiology and Immunology & Medicine, Albert Einstein College of Medicine
Xuan Zhang, M.D., Ph.D., Division of NeuroToxicology, National Center for Toxicological Research, FDA
Yejing Ge, Ph.D., Postdoctoral Fellow, Laboratory of Dr. Elaine Fuchs, Department of Mammalian Cell Biology and Development, Rockefeller University
Ying-Chou Chen, Ph.D., Postdoctoral Associate, Laboratory of Dr. Timothy Lu, Synthetic Biology Center, Massachusetts Institute of Technology
Yoojin Shin, Ph.D., Postdoctoral Fellow, Mechanical Engineering, MIT
Yuan Wang, Ph.D., Investigator III, Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research
Yung-Chih Cheng, Ph.D., Postdoctoral Research Fellow, F.M. Kirby Neurobiology Center, Boston Children’s Hospital, Department of Neurobiology, Harvard Medical School
Yuyu Niu, Ph. D., Associate Director, Yunnan Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, China
Zhao Chen, Ph.D., Investigator III, Exploratory Immuno-Oncology, Novartis Institute of Biomedical Research
Zhenfeng Duan, M.D., Ph.D., Assistant Professor, Orthopedic Surgery, Harvard Medical School and Massachusetts General Hospital
Zohreh Amoozgar, Pharm.D., Ph.D., Postdoctoral Research Fellow, Radiation Oncology, MGH, Harvard Medical School
Yung-Chih Cheng, Ph.D., Postdoctoral Research Fellow, F.M. Kirby Neurobiology
Yuyu Niu, Ph. D., Associate Director, Yunnan Key Laboratory of Primate Biomedical
Zhao Chen, Ph.D., Investigator III, Exploratory Immuno-Oncology, Novartis Institute
Zhenfeng Duan, M.D., Ph.D., Assistant Professor, Orthopedic Surgery, Harvard
Zohreh Amoozgar, Pharm.D., Ph.D., Postdoctoral Research Fellow, Radiation